Boston Scientific introduces flexible hemostatic clip

A new hemostatic clipping device will soon enter the market as a technology designed to give physicians more control when placing clips on a patient’s gastrointestinal tract.

The Resolution 360 Clip, designed by Boston Scientific, will be introduced at the annual United Europeans Gastroenterology Week in Vienna, Austria, and then again at the American College of Gastroenterology in Las Vegas. Physicians who attend the meetings will have a chance to use the device in a simulator, Boston Scientific said in a statement.

The clip can be used in several endoscopy procedures of the upper and lower gastrointestinal tract. It’s designed to stop and prevent bleeding stemming from peptic ulcers, polyps removed during a colonoscopy and diverticulosis of the colon.

"The Resolution 360 Clip gives me the unique advantage of controlling the movement and placement of the clip while also maneuvering the scope during the clipping procedure," said David L. Carr-Locke, MD, chief of digestive diseases at Mount Sinai Beth Israel Medical Center in New York, in a statement. "The ability to have complete control can help improve the accuracy of clip placement and the speed of the procedure particularly in complex cases."

The Resolution 360 Clip is constructed with a multi-wire braided catheter, which lets a doctor rotate the device in small, controlled movements that will prevent bleeding.

"We are always striving to improve our technology so that physicians have the tools they need to diagnose and treat gastrointestinal disease more easily and effectively," said Art Butcher, senior vice president and president of endoscopy at Boston Scientific, in a statement. "Building on the legacy Resolution Clip and its clinically proven technology, the expanded portfolio now offers physicians more hemostatic clipping options to consider in different clinical situations and patient anatomies."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.